Infant Bacterial Therapeutics AB
556873-8586ActiveDeveloping novel biotherapeutics for premature infant diseases through rigorous clinical trials.
Pharmaceutical Companyibtherapeutics.com
Yleiskatsaus
- 5–9
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2011
- Perustettu
Avainpäättäjät
Staffan Strömberg
CEO
Thomas J. Schnitzer
Chief Scientific Officer
Kristina Sjöblom Nygren
Board Member
Sanjiv Sharma
Head of Medical Affairs
+10 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Infant Bacterial Therapeutics AB (IBT) is a specialized pharmaceutical company focused on developing and commercializing novel drugs specifically targeting diseases affecting premature infants. The company addresses significant unmet medical needs, such as Necrotizing Enterocolitis (NEC), gastroschi...